BRPI0814658A2 - Composição farmacêutica líquida estável - Google Patents

Composição farmacêutica líquida estável

Info

Publication number
BRPI0814658A2
BRPI0814658A2 BRPI0814658-6A2A BRPI0814658A BRPI0814658A2 BR PI0814658 A2 BRPI0814658 A2 BR PI0814658A2 BR PI0814658 A BRPI0814658 A BR PI0814658A BR PI0814658 A2 BRPI0814658 A2 BR PI0814658A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
stable net
net pharmaceutical
stable
composition
Prior art date
Application number
BRPI0814658-6A2A
Other languages
English (en)
Portuguese (pt)
Inventor
Marcello Marchetti
Lorella Ragni
Paolo Scarpetti
Mauro Valenti
Francesca Mariotti
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of BRPI0814658A2 publication Critical patent/BRPI0814658A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BRPI0814658-6A2A 2007-07-31 2008-07-22 Composição farmacêutica líquida estável BRPI0814658A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001573A ITMI20071573A1 (it) 2007-07-31 2007-07-31 Composizione farmaceutica liquida stabile a base di trazodone
PCT/EP2008/059605 WO2009016069A2 (en) 2007-07-31 2008-07-22 Stable liquid pharmaceutical composition based on trazodone

Publications (1)

Publication Number Publication Date
BRPI0814658A2 true BRPI0814658A2 (pt) 2015-02-18

Family

ID=38858941

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0814658-6A2A BRPI0814658A2 (pt) 2007-07-31 2008-07-22 Composição farmacêutica líquida estável

Country Status (25)

Country Link
US (1) US10292931B2 (hr)
EP (2) EP2182920B1 (hr)
JP (1) JP5426548B2 (hr)
KR (1) KR101493370B1 (hr)
CN (1) CN101784257B (hr)
AR (1) AR068327A1 (hr)
AU (1) AU2008281858B2 (hr)
BR (1) BRPI0814658A2 (hr)
CA (1) CA2692975C (hr)
CY (1) CY1116189T1 (hr)
DK (2) DK2182920T3 (hr)
EA (1) EA016822B1 (hr)
ES (2) ES2399569T3 (hr)
GE (1) GEP20125525B (hr)
HK (2) HK1138207A1 (hr)
HR (1) HRP20150349T1 (hr)
IL (1) IL203167A (hr)
IT (1) ITMI20071573A1 (hr)
MX (1) MX2010001092A (hr)
PL (2) PL2182920T3 (hr)
PT (2) PT2182920E (hr)
SG (1) SG183659A1 (hr)
SI (2) SI2494955T1 (hr)
UA (1) UA102376C2 (hr)
WO (1) WO2009016069A2 (hr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20071603A1 (it) 2007-08-03 2009-02-04 Acraf Trazodone e trazodone cloridrato in forma purificata
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
RU2706700C1 (ru) * 2019-09-24 2019-11-20 Общество с ограниченной ответственностью "Научно-производственная компания "СКиФФ" Фармацевтическая композиция для коррекции поведения кошек и собак в стрессовых ситуациях
KR20220080096A (ko) 2019-09-26 2022-06-14 안젤리니 에스.피.에이. 소아용 트라조돈 조성물 및 이의 치료 방법
CN111568861A (zh) * 2020-05-25 2020-08-25 河北科星药业有限公司 畜禽用盐酸溴己新口服液及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4154832A (en) * 1974-08-26 1979-05-15 Bruno Silvestrini Novel treatment for acute organic cerebral syndromes (strokes)
IT1233412B (it) * 1987-12-02 1992-03-30 Acraf Uso del trazodone
US6251428B1 (en) * 1998-07-24 2001-06-26 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
AU2003903597A0 (en) 2003-07-11 2003-07-24 Jakov Vaisman Treatment of premature ejaculation
ITMI20071603A1 (it) 2007-08-03 2009-02-04 Acraf Trazodone e trazodone cloridrato in forma purificata

Also Published As

Publication number Publication date
DK2494955T3 (en) 2015-04-13
EP2182920A2 (en) 2010-05-12
ES2399569T3 (es) 2013-04-02
UA102376C2 (ru) 2013-07-10
AU2008281858B2 (en) 2014-02-27
AR068327A1 (es) 2009-11-11
SI2494955T1 (sl) 2015-04-30
HK1176280A1 (en) 2013-07-26
MX2010001092A (es) 2010-03-01
EP2494955A3 (en) 2012-10-03
EP2494955B1 (en) 2015-01-21
EA201070194A1 (ru) 2010-06-30
DK2182920T3 (da) 2013-03-04
JP5426548B2 (ja) 2014-02-26
US20100256159A1 (en) 2010-10-07
CN101784257B (zh) 2012-11-28
EP2182920B1 (en) 2012-12-26
CA2692975A1 (en) 2009-02-05
PL2182920T3 (pl) 2013-05-31
WO2009016069A4 (en) 2009-05-14
ITMI20071573A1 (it) 2009-02-01
SI2182920T1 (sl) 2013-04-30
WO2009016069A2 (en) 2009-02-05
IL203167A (en) 2017-08-31
PT2494955E (pt) 2015-03-04
AU2008281858A1 (en) 2009-02-05
PT2182920E (pt) 2013-03-07
EA016822B1 (ru) 2012-07-30
WO2009016069A3 (en) 2009-03-19
KR20100038112A (ko) 2010-04-12
JP2010534703A (ja) 2010-11-11
KR101493370B1 (ko) 2015-02-13
CA2692975C (en) 2016-01-12
ES2531241T3 (es) 2015-03-12
HRP20150349T1 (hr) 2015-05-22
SG183659A1 (en) 2012-09-27
GEP20125525B (en) 2012-05-25
CN101784257A (zh) 2010-07-21
PL2494955T3 (pl) 2015-06-30
US10292931B2 (en) 2019-05-21
CY1116189T1 (el) 2017-02-08
HK1138207A1 (en) 2010-08-20
EP2494955A2 (en) 2012-09-05

Similar Documents

Publication Publication Date Title
LTPA2018005I1 (lt) Farmacinė kompozicija
LTPA2018014I1 (lt) Farmacinė kompozicija 514
BRPI0721651A2 (pt) Composição farmacêutica
DK3492069T3 (da) Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
BRPI0715712A2 (pt) Composição farmacêutica
BRPI0820381A2 (pt) Formulações farmacêuticas
BRPI0719393A2 (pt) Composição farmacêutica
DK2120884T3 (da) Farmaceutisk sammensætning
BRPI0810928A2 (pt) "composição farmacêutica"
BRPI0810898A2 (pt) composições agroquímicas
BRPI0716445A2 (pt) composiÇço farmacÊutica
DK2180882T3 (da) Farmaceutisk faststofsammensætning af matrix-type
BRPI0720234A2 (pt) Composição farmacêutica
DK2285413T3 (da) Farmaceutisk sammensætning
DK2285357T3 (da) Farmaceutisk sammensætning omfattende brivaracetam
BRPI0921313A2 (pt) composição farmaucêutica
BRPI0813692A2 (pt) Composição pesticida
BRPI0817833A2 (pt) Composição farmacêutica antimalárica
BRPI0820198A2 (pt) composições farmacêuticas
DK2966175T3 (da) Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
FR2920271B1 (fr) Composition pesticide
BRPI0912171A2 (pt) composição farmacêutica
BRPI0809653A2 (pt) Formulações líquidas de manoproteína
ATE480227T1 (de) Pharmazeutische zusammensetzungen mit quetiapinfumarat
DK2271321T3 (da) Farmaceutisk sammensætning 271

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07E Notice of approval relating to section 229 industrial property law
B07A Technical examination (opinion): publication of technical examination (opinion)
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application according art. 36 industrial patent law
B09B Decision: refusal
B12B Appeal: appeal against refusal